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Abstract 
Electronic health records (EHRs) can provide researchers with extraordinary 
opportunities for population based research. The National Health Insurance 
system of Taiwan was established in 1995 and covers more than 99.6% of the 
Taiwanese population; this system’s claims data are released as the National 
Health Insurance Research Database (NHIRD). All data from primary outpatient 
departments and inpatient hospital care settings after 2000 are included in this 
database. After a change and update in 2016, the NHIRD is maintained and 
regulated by the Data Science Centre of the Ministry of Health and Welfare of 
Taiwan. Datasets for approved research are released in three forms: sampling 
datasets comprising two million subjects, disease-specific datasets, and full 
population datasets. These datasets are de-identified and contain basic 
demographic information, disease diagnoses, prescriptions, operations, and 
investigations. Data can be linked to governmental surveys or other research 
datasets. While only a small number of validation studies with small sample sizes 
have been undertaken, they generally report positive predictive values of over 
70% across different diagnoses. Currently, patients cannot opt out of inclusion in 
the database, though this requirement is under review. In conclusion, the NHIRD 
is a large, powerful data source for biomedical research. 
 
Keywords: database, electronic health records, information storage and retrieval, 
National Health Insurance Research Database (NHIRD), Taiwan  
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Introduction 
The increasing availability, size and detail of electronic health records (EHRs) 
offer unprecedented opportunities for research. The advantages of EHRs include 
increased statistical power, speed, wide breadth, relatively low cost, 
representative population coverage, completeness of follow-up and the ability to 
assess interventions in routine clinical care (1). Linking EHRs to disease 
registries and other resources can further extend their utility. Conversely, 
randomised controlled trials (RCTs) control for known and unknown confounding 
factors; therefore, they are regarded as the gold standard for measuring the 
efficacy of interventions (2). However, the true effectiveness of exposures may 
be influenced by many factors in a real-world setting, leading to a gap between 
efficacy and effectiveness. Consequently, real-world data, collected in non-
randomised controlled trial settings, are essential to bridging this gap (3). An 
important source of real-world data is EHRs, which have become a practical tool 
in medical research. By utilising EHRs, researchers can measure treatment 
effects, demonstrate trends in disease incidence and prevalence, and further 
explore possible disease aetiologies.  
Among national EHRs databases all over the world, the National Health 
Insurance Research Database (NHIRD) of Taiwan is unique. This large database, 
which contains data from 23 million residents of Taiwan, was previously 
described by Chen et al (4). However, the NHIRD was updated in 2016. This 
database changed its regulatory administration, integrated with other datasets for 
further linkage, and released its full population dataset. Now NHIRD provides 
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greater flexibility for scientific research. In this article, we introduce the latest 
version of the NHIRD, demonstrate its key features for research, and describe its 
strengths and weaknesses.  
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Basic Data Resources 
National Health Insurance Programme of Taiwan 
To increase the affordability and accessibility of health care, in 1995, the 
Taiwanese government initiated a single-payer health insurance system called 
National Health Insurance (NHI). NHI has a contract with most healthcare 
facilities in Taiwan, and it is mandatory for physicians to upload the claims data 
from each visit to the National Health Insurance Ministry. Notably, the primary 
care system in Taiwan is different from that of many other countries. Referrals 
from general practitioners are not required to receive specialist care; therefore, 
patients with non-emergency health concerns can either visit local private or 
public clinics or go directly to specialists in hospital outpatient departments (5). In 
2017, 93% of healthcare facilities in Taiwan contracted with NHI, except some 
self-pay private clinics. (6) As a universal health coverage care, NHI covers all 
necessary medical expenses including outpatient visits, the inpatient system, 
prescriptions, Chinese medicine treatment, dental services, operations, and such 
investigations as X-ray or MRI. The coverage of NHI reached 92% as it 
established; by the end of 2014, NHI covered 99.9% of the Taiwanese population 
(7, 8).  
History of Insurance Data Usage and Governance  
In 2000, the anonymous and encrypted sampling dataset from this national 
insurance system was first released for use in research, which is regulated and 
maintained by the National Health Research Institutes of Taiwan. From 2000 to 
2013, the National Health Research Institutes made available to researchers 
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general sampling datasets with one-million subjects, as well as specific disease 
sampling datasets. In 2016, these insurance data were moved into the Data 
Science Centre of the Ministry of Health and Welfare of Taiwan, where data are 
regulated and managed by the government (9). The regulatory structure of the 
NHIRD is illustrated in Figure 1. The claims data from the NHI are stored and 
processed in the Data Science Centre, along with other governmental surveys 
and datasets. At the Data Science Centre, the NHIRD and other datasets are 
compared with the Household Registry Record from the Ministry of the Interior for 
quality control. Variables, such as sex and dates, are examined to ensure the 
accuracy and consistency across different years. All data are de-identified and 
encrypted to protect participants’ privacy (10).  
Research Using NHIRD Data 
The NHIRD is a powerful tool for observing chronic diseases and assessing the 
effects of treatments. For instance, hepatitis B virus (HBV) and hepatitis C virus 
(HCV) infections are relatively prevalent in Taiwan. Previous studies using the 
NHIRD demonstrated that using statins, medicines for decreasing low-density 
lipoprotein (LDL) in the blood, was associated with a decreased incidence of 
hepatocellular carcinoma (HCC) in HBV and HCV patients (8, 9). Another study 
showed that nucleoside analogues used as antiviral treatments for chronic 
hepatitis B, reduced HCC recurrence in HBV patients receiving liver resection 
(11). Furthermore, the availability of data linkage makes it possible to conduct 
population-based studies of rare diseases. By using NHIRD data, Kuo et al 
demonstrated an increased heritable risk of systemic lupus erythematosus (SLE) 
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and other autoimmune diseases among families of SLE patients (12). After 2014, 
each year more than 300 published studies used NHIRD data (Figure 2). To date, 
there have been over 2,700 peer-reviewed studies published using NHIRD data, 
covering such topics as general medicine, multidisciplinary science, psychiatry, 
clinical neurology, oncology and public environmental and occupational health.   
Measurement 
Practice and Patient Data 
The basic structure of NHIRD data is shown in Figure 3. These de-identified data 
contain demographic variables, including the insured persons’ registration 
location, sex, age, investigations, diagnosis, prescriptions and details of each 
outpatient visit or their inpatient care. Disease diagnoses are coded using the 
International Classification of Diseases version 9 (ICD-9). Each subject in the 
data is coded with an encrypted identifier, which can be used to link their future 
patient data. Detailed laboratory test results and medical notes are not included 
in this database. 
Data Release 
The NHIRD data are released in three forms. The first form is a general dataset 
containing two-million patients. Two million subjects are collected using stratified 
random sampling by age, sex and registry of regions from the full database 
population. They were sampled at three different time points: 2000, 2005, and 
2010. Each dataset contains claims data including diagnoses, prescriptions, 
investigation items and treatments that the subjects received from 2000 to 2016. 
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For datasets sampled in 2005 and 2010, there are two additional datasets 
available: from 2005 to 2016 and from 2010 to 2016. In addition to the complete 
claims data, these sampling datasets also contain data from cause of death 
datasets, cancer registry datasets, major illness datasets and hospital 
information datasets. The general two million patient sampling dataset is 
considered to be nationally representative. 
The second form of NHIRD data is a disease-specific dataset. This dataset 
contains complete claims data of all patients with a certain health condition. For 
instance, all patients with a diabetes diagnosis from 2002 to 2015 are included in 
the diabetes dataset. As of 2018, there are 13 disease-specific databases 
available for research (Table 1.) These datasets can also be linked to cancer-
registration data and cause of death data.  
The third form of NHIRD data is the full population dataset, which has been 
available for research since 2016. The full population dataset covers the entire 
Taiwanese population from 2000 to 2016, which comprises approximately 23 
million people. Researchers can apply for complete claims data, including 
inpatient and outpatient records, investigations and treatment, which can be 
linked with hospital information, birth certificate application, death records, cancer 
registry dataset, and major illness datasets. Furthermore, the full population data 
can also be linked with an individual dataset, a feature that will be introduced 
later. These released datasets are a valuable source for epidemiological 
research.  
Data Linkage 
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Since 2016, under the authorisation and regulation of the Ministry of Health and 
Welfare, NHIRD data can be more widely linked with other public surveys in the 
Data Science Centre. These datasets include governmental surveys, disease 
registries, health surveys, social reporting system data, and welfare registry data. 
Detailed descriptions of these databases are given in Table 2. These databases 
and the NHIRD can be linked through an encrypted personal ID using a 
deterministic record linkage. Due to privacy issues, this data linkage can only be 
processed by researchers in the Data Science Centre. Accessing some sensitive 
data, such as the domestic violence database, requires special authorisation 
from other administrative departments. In addition to linking governmental data, 
with the informed consent of study subjects, researchers are also allowed to link 
their own research database with the NHIRD. For instance, the Taiwan Biobank 
Database is a national cohort containing biological samples and comprehensive 
examinations of 200,000 adult volunteers that is going to be linked to the NHIRD 
(13). Such data linkages can help researchers discover possible interactions 
among genes, environmental factors and diseases.   
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Strengths and Weaknesses 
Strengths 
The NHIRD is a nationally representative cohort, containing detailed registry and 
claims data from all 23 million residents of Taiwan. This huge database provides 
researchers with powerful and generalisable real-world evidence for biomedical 
studies. For instance, a molecular epidemiological study has suggested that 
aristolochic acid (AA), an ingredient in Chinese herbal remedies, is correlated to 
hepatocellular carcinoma (HCC) in Taiwan and other Asian countries (14). 
Similar findings were later found from using NHIRD data. Chen et al. analysed 
NHIRD data and discovered that using Chinese herbs containing AA increased 
risk of HCC among patients with hepatitis B virus infection (15). In addition, after 
the update in 2016, the NHIRD can be further linked with other datasets to 
increase the power and potential to research specific population subgroups, rare 
conditions and factors that are not usually contained in clinical databases such 
as living conditions, violence or detailed lifestyle data. The payment and 
imbursement data are also valuable for health economic analysis.  
Weaknesses 
There are some issues with the NHIRD. First, the NHIRD lacks comprehensive 
validation, although some validation studies of the clinical diagnoses in the 
NHIRD have been done. Some of these validation studies used national disease 
registries as their reference standards, which is more convincing. Other studies 
have used hospital-based records to validate the diagnoses found in the NHIRD 
and have reported relatively high positive predictive values over 70% 
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(Supplementary Table 2). However, the sample size of these studies were small 
and drawn from a limited number of hospitals. Therefore, the samples may not 
be regarded as nationally representative. To improve the accuracy of the NHIRD, 
the Ministry of Health and Welfare of Taiwan recently initiated a national 
validation project using existing registry data (16). However, until this new 
evidence of the database’s validity is reported, researchers should carefully 
interpret results from the NHIRD. Second, consent from the participants included 
in the NHIRD is another controversial issue. By law, all residents in Taiwan are 
required to have National Health Insurance, and their data will be included in the 
NHIRD; there is currently no way for participants to opt out of this national cohort. 
However, in 2017, the Supreme Administrative Court upheld the legitimacy of 
using the NHIRD data for research (17). People’s ability to opt out of inclusion in 
the NHIRD remains under discussion (18). Finally, records of self-pay healthcare 
and out-of-pocket payments, such as cosmetic surgeries, are not included in 
NHIRD. This may narrow the scope of research using NHIRD, and researchers 
must be aware of the effects of these non-included variables.  
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Data Access  
Researchers can access NHIRD data after ethical and scientific review 
processes. Prior to applying, researchers must obtain an approval from the 
institutional review board (IRB). Notably, the applicant must be Taiwanese or be 
affiliated with a Taiwanese research institute. Applicants should submit their 
research proposal to the Data Science Centre. Proposals should include specific 
methods and variables required for their analyses. The cost of accessing data 
depends on the number of variables requested and time period that they require 
the data for analyses; for example, accessing one variable for one year would 
cost 200 New Taiwanese Dollars. After receiving an application, the Ministry of 
Health and Welfare will review the legitimacy of the proposal, which is later 
reviewed by a scientific committee consisting of three experts. If one of the 
committee member disagrees with the proposed use of the data, then 
researchers must submit a revised proposal to a higher advisory committee for a 
second review.  
After receiving approval, researchers must go to the branches of the Data 
Science Centre to do their data analyses. The analyses of NHIRD data is 
complicated, and there is no structural training course for using the NHIRD. 
Therefore, a mock dataset containing 100,000 subjects is provided by the Data 
Science Centre to help researchers in writing statistical analysis syntax. When 
researchers enter the Data Science Centre, they are allowed to use provided 
computers and software including SAS, STATA, R and SPSS to do their data 
analyses (19).   
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Ethics and Confidentiality  
Ethical review board approval is mandatory when applying to use NHIRD data. 
There are 27 institutional review boards capable of issuing approvals, and all are 
supervised and regulated by the Ministry of Health and Welfare (20). To protect 
individuals’ confidentiality, all datasets in the Data Science Centre are 
pseudonymised. Personal ID, birth date and names are encrypted, and this de-
identification process was approved by an independent third party organisation 
(19). To further secure the participants’ privacy, NHIRD datasets cannot be 
accessed outside the Data Science Centre, so researchers must analyse these 
datasets at the Data Science Centre. When accessing the Data Science Centre, 
researchers are not allowed to bring any recording devices, including paper and 
pen. In addition, their statistical analysis syntax needs to be reviewed by the Data 
Science Centre prior to using the computers and software provided. The 
analysed results will also be examined by the Data Science Centre before 
exporting. Any results using less than 3 subjects will not be allowed to be 
exported to prevent re-identification (21).  
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Conclusions 
The National Taiwan Health Insurance Research Database contains a large 
quantity of claims data and has the potential for multiple data linkages. Although 
more validation research is needed, and regulatory work to protect privacy is 
ongoing, this nationwide cohort is a valuable resource for medical research. 
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Figure and Tables 
Figure 1. The Administrative Structure of the National Health Insurance Research 
Database (22)  
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Figure 2. Publications Using the NHIRD from 2000 to 2018 
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Figure 3. The Data Structure of NHIRD 
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Table 1. Diseases-specific Database of NHIRD 
Database Name Year New Case 
Number 
Colorectal Cancer Health Database 2002-2015 175,405 
Breast Cancer Health Database 2002-2015 136,476 
Prostate cancer health database 2002-2015 53,937 
Systemic Lupus Erythematosus 
Health Database 
2002-2015 29,637 
Hypertension 2002-2015 3,342,827 
Brain Tumor Health Database 2002-2015 10,267 
Chronic Kidney Disease Health 
Database 
2002-2015 1,066,892 
End-Stage Renal Disease Health 
Database  
2002-2015 134,228 
Diabetes Mellitus Health Database 2002-2015 1,720,602 
Injury Database 2000-2015 25,925,939 
Triple-High Database** 2001-2015 6,558 
Disability Process Database 1996,1999, 
2003,2007,2011 
6935 
Maternal and Child Health Database 2004-2014 2,171,765 
* Triple-High: Hypertension, hyperglycemia, hyperlipidemia  
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Table 2. Database Available for Linkage 
Name of Database Following 
Years 
Health Data   
Taiwan Cancer Registry 2007-2012 
Cause of Death Data 1971-2014 
Birth Certificate Applications 2001-2013 
Traffic Accident Data 2003-2014 
“Triple-high status” Survey 2006-2007 
Taiwan Birth Cohort Study 2005 
“Knowledge, Attitude, and Practice of Contraception” Survey 1965-2008 
Taiwan Youth Health Survey File 2006-2010 
Rare Disease Data 2012 
Artificial Reproductive Data 1998-2012 
Cancer Screening – pap smear data 2004-2013 
Colorectal cancer screening 2010-2013 
Breast cancer screening 2004-2013 
Oral Mucosal Screening 2010-2013 
Taiwan Healthy Behaviour Risk Factor Surveillance Survey File 2007-2012 
  
Society Survey  
National Aboriginal population profile 2006-2012 
Personal Data for the sampled NHI claims cohorts 2000, 2005 
National Health Interview Survey 2001-2009 
Taiwan Longitudinal Study in Aging 1998-2011 
Taiwan Smoking Behaviour survey 2004-2009 
  
Welfare Database  
The Juvenile Condition Survey in Taiwan-Fuchien Area 2003 
Report of the Home Care Subsidy User Condition Survey 2007 
The Satisfaction with Home Care Services Survey 2011 
The Low-income and Middle-income Family Living Condition 
Survey 
2013 
Taiwan Longitudinal Study in Aging 2009-2013 
Physically and mentally disabled citizens living and demand 
assessment survey 
2011 
Single Parent Family Condition Survey 2010 
Women living conditions survey 1998-2011 
Disabled population profile 2014 
Low-income and middle-low-income households data 2014 
Family violence data 2011-2014 
Reported Data of Protection of Child and Youths 2011-2014 
Reported Data of Sexual Assault 2011-2014 
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